Clinical trial
Study Of Healthy Subjects To Assess The Effect Of Ketoconazole And The Way The…
NCT00404378 · GlaxoSmithKline, Industry · Completed
Key facts
| NCT number | NCT00404378 |
|---|---|
| Title | Study Of Healthy Subjects To Assess The Effect Of Ketoconazole And The Way The Body Will React To Casopitant [GW679769] |
| Official title | An Open-label, Two Period, Fixed Sequence Study of Healthy Subjects to Assess the Effect of Repeat Oral Dosing of Ketoconazole on the Pharmacokinetics of a Single Oral Dose of [GW679769] |
| Lead sponsor | GlaxoSmithKline, Industry |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Nausea and Vomiting, Chemotherapy-Induced |
| Intervention type | Drug |
| Interventions | ketoconazole, casopitant 100 mg, Casopitant 50 mg |
| Enrollment | 15 |
| Start date | Oct 20, 2006 |
| Primary completion | Jan 5, 2007 |
| Completion | Jan 5, 2007 |
| First posted | Nov 28, 2006 |
| Last update posted | Sep 12, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: